NASDAQ:ADMS
Delisted
Adamas Pharmaceuticals Stock News
$8.22
+0 (+0%)
At Close: May 27, 2022
Adamas Pharmaceuticals Inc Files For Common Stock Offering Of Up To $50M
12:00am, Tuesday, 03'rd Dec 2019Adamas to Present at Upcoming Evercore ISI and Piper Jaffray Investor Conferences
12:00am, Thursday, 21'st Nov 2019The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
12:00am, Friday, 08'th Nov 2019Adamas Pharmaceuticals Q3 EPS $(0.99) Misses $(0.89) Estimate, Sales $13.933M Miss $14.07M Estimate
12:00am, Thursday, 07'th Nov 2019Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
12:00am, Thursday, 31'st Oct 2019The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
12:14pm, Friday, 11'th Oct 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 10.) The Medicines Company (NASDAQ: MDCO ) Ra
The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO
11:31am, Thursday, 10'th Oct 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed Oct.
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
11:58am, Wednesday, 09'th Oct 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-week highs on Tuesday. Down In The Dumps (Biotech st
